Just 3.2% of adult smokers with peripheral artery disease (PAD) were prescribed the smoking-cessation drug varenicline, according to a new study. Smoking is the leading modifiable risk factor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results